Literature DB >> 3552176

The effect of cephalothin prophylaxis on postoperative ventriculoperitoneal shunt infections.

M J Rieder, T C Frewen, R F Del Maestro, A Coyle, S Lovell.   

Abstract

Postoperative infection is an important complication after insertion of a ventriculoperitoneal (VP) shunt in children with hydrocephalus. A randomized double-blind placebo-controlled study was performed to determine the efficacy of cephalothin in preventing postoperative shunt infection. Sixty-three children who presented for elective VP shunt insertion between January 1982 and December 1985 and who did not have a history of shunt infections were randomly assigned to receive four doses of prophylactic cephalothin, 25 mg/kg (32 patients), or of a multivitamin placebo (31 patients). Postoperative infection developed in 6% of the treatment group, compared with 10% of the placebo group, a difference that was not statistically significant, although a clinical significance may have been masked by the small sample size. A large multicentre trial is needed to determine the efficacy of antibiotic prophylaxis in reducing the incidence of postoperative VP shunt infections.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552176      PMCID: PMC1491956     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  22 in total

1.  Follow-up analysis of ventriculoperitoneal and ventriculoatrial shunts for hydrocephalus.

Authors:  R J Ignelzi; W M Kirsch
Journal:  J Neurosurg       Date:  1975-06       Impact factor: 5.115

2.  Antibiotic prophylaxis in shunt surgery.

Authors:  R Bayston
Journal:  Dev Med Child Neurol Suppl       Date:  1975

3.  Control of shunt infection. Report of 150 consecutive cases.

Authors:  J L Venes
Journal:  J Neurosurg       Date:  1976-09       Impact factor: 5.115

4.  Adult hydrocephalus. Evaluation of shunt therapy in 80 patients.

Authors:  J H Salmon
Journal:  J Neurosurg       Date:  1972-10       Impact factor: 5.115

Review 5.  Meta-analysis: quantitative integration of independent research results.

Authors:  T R Einarson; W F McGhan; J L Bootman; D L Sabers
Journal:  Am J Hosp Pharm       Date:  1985-09

6.  Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience.

Authors:  R George; L Leibrock; M Epstein
Journal:  J Neurosurg       Date:  1979-12       Impact factor: 5.115

7.  Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy.

Authors:  S C Schoenbaum; P Gardner; J Shillito
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

8.  Complications of ventriculo-peritoneal shunting and a critical comparison of the three-piece and one-piece systems.

Authors:  A J Raimondi; J S Robinson; K Kuwawura
Journal:  Childs Brain       Date:  1977

9.  Long-term results after ventriculoatrial and ventriculoperitoneal shunting for infantile hydrocephalus.

Authors:  T R Keucher; J Mealey
Journal:  J Neurosurg       Date:  1979-02       Impact factor: 5.115

10.  Prevention of neurosurgical infection by intraoperative antibiotics.

Authors:  L I Malis
Journal:  Neurosurgery       Date:  1979-09       Impact factor: 4.654

View more
  8 in total

1.  Prophylactic antibiotics in pediatric shunt surgery.

Authors:  N Biyani; G Grisaru-Soen; P Steinbok; S Sgouros; S Constantini
Journal:  Childs Nerv Syst       Date:  2006-05-18       Impact factor: 1.475

2.  Antibiotic prophylaxis in cerebrospinal fluid shunting: a prospective randomized trial in 129 patients.

Authors:  J Zentner; J Gilsbach; T Felder
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

3.  Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts.

Authors:  B M Borgbjerg; F Gjerris; M J Albeck; S E Børgesen
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  Route of antibiotic prophylaxis for prevention of cerebrospinal fluid-shunt infection.

Authors:  Sebastian Hhmj Arts; Hieronymus Damianus Boogaarts; Erik J van Lindert
Journal:  Cochrane Database Syst Rev       Date:  2019-06-04

5.  Cerebrospinal Fluid Shunt Infection: Emerging Paradigms in Pathogenesis that Affect Prevention and Treatment.

Authors:  Tamara D Simon; Joshua K Schaffzin; Charles B Stevenson; Kathryn Willebrand; Matthew Parsek; Lucas R Hoffman
Journal:  J Pediatr       Date:  2018-12-06       Impact factor: 4.406

6.  Antibiotic single-dose prophylaxis of shunt infections.

Authors:  J Blum; M Schwarz; D Voth
Journal:  Neurosurg Rev       Date:  1989       Impact factor: 3.042

Review 7.  Antibiotic prophylaxis for shunt surgery of children: a systematic review.

Authors:  H Xu; F Hu; H Hu; W Sun; W Jiao; R Li; T Lei
Journal:  Childs Nerv Syst       Date:  2015-10-23       Impact factor: 1.475

8.  A randomized controlled trial of perioperative rifampin/trimethoprim in cerebrospinal fluid shunt surgery.

Authors:  B C Walters; L Goumnerova; H J Hoffman; E B Hendrick; R P Humphreys; C Levinton
Journal:  Childs Nerv Syst       Date:  1992-08       Impact factor: 1.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.